|
LUC7L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.840400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.628000E-01 |
| Normal-vs-Stage2 |
8.959200E-01 |
| Normal-vs-Stage3 |
1.932620E-01 |
| Normal-vs-Stage4 |
2.457800E-01 |
| Stage1-vs-Stage2 |
6.329000E-01 |
| Stage1-vs-Stage3 |
1.289780E-01 |
| Stage1-vs-Stage4 |
9.451600E-02 |
| Stage2-vs-Stage3 |
3.930000E-01 |
| Stage2-vs-Stage4 |
4.744400E-01 |
| Stage3-vs-Stage4 |
8.335400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.126200E-01 |
| Normal-vs-AfricanAmerican |
8.154400E-01 |
| Normal-vs-Asian |
2.192000E-01 |
| Caucasian-vs-AfricanAmerican |
2.409200E-01 |
| Caucasian-vs-Asian |
5.495600E-02 |
| AfricanAmerican-vs-Asian |
5.398200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.011000E-01 |
| Normal-vs-Female |
4.651600E-01 |
| Male-vs-Female |
9.416200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.608800E-01 |
| Normal-vs-Extreme_Weight |
5.741200E-01 |
| Normal-vs-Obese |
4.093800E-01 |
| Normal-vs-Extreme_Obese |
9.358200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.401800E-01 |
| Normal_Weight-vs-Obese |
2.879800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.933600E-01 |
| Extreme_Weight-vs-Obese |
8.769800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.643000E-01 |
| Obese-vs-Extreme_Obese |
6.327000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.903600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.667800E-02 |
| Normal-vs-Age(61-80Yrs) |
9.904000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.316400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.448000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.759400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.441800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.947600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.530000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.662400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.335140E-03 |
| Normal-VS-Type2 PRCC |
8.813600E-04 |
| Normal-VS-KIRP CIMP |
2.521800E-01 |
| Normal-VS-Unclassified PRCC |
9.507200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.26329946503745E-10 |
| Type1 PRCC-VS-KIRP CIMP |
7.096500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.459500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.901200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.147800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.153400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.814100E-02 |
| Normal-vs-N1 |
5.799200E-01 |
| Normal-vs-N2 |
6.823800E-01 |
| N0-vs-N1 |
3.676000E-01 |
| N0-vs-N2 |
6.529400E-01 |
| N1-vs-N2 |
9.971600E-01 |
|
|
